Pfizer (NYSE:PFE) recently received a CDC recommendation for wider use of its RSV vaccine, ABRYSVO, in adults aged 50-59 at ...

Pfizer's strong R&D pipeline, 7.5%+ dividend yield, & undervalued PE ratio make PFE stock a compelling investment opportunity ...

UC San Diego's Moores Cancer Center has received a $1 million donation from pharmaceutical giant Pfizer to support early ...

Pfizer abandoned the development of danuglipron and plans to focus its efforts on GIPR candidates and other earlier obesity programs.

Screening tests are critical in early detection because they can find cancer before symptoms appear, when treatment is more ...

A key vaccine advisory committee is meeting for the first time under new U.S. Health Secretary Robert F. Kennedy Jr., a ...

Myriad reasons underlie the negative sentiment toward the healthcare sector, but in some instances, this dour take isn't entirely warranted. Pharmaceutical titan Pfizer (NYSE: PFE) is a case in point.

Moores Cancer Center at the University of California San Diego has received a $1 million donation from pharmaceutical company ...

Now given Pfizer's growing pipeline of new drug launches ... other mechanisms of action to address this growing global health challenge. Pfizer has a huge pipeline of new drugs that can hit ...

Pfizer has unveiled its new research and development centre in Beijing, marking a significant step in the company's strategic expansion in China.